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Abstract
African Americans (AAs) who use cocaine in the Southern region of the U.S. have a relatively 
high risk of HIV and need for HIV testing. Among this group, those residing in rural areas may 
have less favorable opinions about common HIV testing sites, which could inhibit HIV testing. We 
examined rural/urban variations in their acceptability of multiple HIV testing sites (private 
physician clinic, local health department, community health center, community HIV fair, hospital 
emergency department, blood plasma donation center, drug abuse treatment facility, and mobile 
van or community outreach worker). Results from partial proportional odds and logistic regression 
analyses indicate that rural AA who use cocaine have lower odds of viewing local health 
departments (OR=0.09, 95%CI=0.03–0.21), physician offices (OR=0.19, 95%CI=0.09–0.42), and 
drug use treatment centers (OR=0.49; 95% CI=0.30–0.80) as acceptable relative to their urban 
counterparts. The findings have implications for further targeting HIV testing toward AAs who use 
of cocaine, particularly those residing in the rural South.
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INTRODUCTION
African Americans (AAs) overall have a relatively high risk of HIV/AIDS. According to 
Centers for Disease Control and Prevention (CDC) estimates, the HIV incidence rate is 
approximately 7 times greater among AAs than whites (1). Among AAs, cases of AIDS 
declined in all U.S. Census regions in recent years except the South (2). In fact, more than 
50% of AAs reside in the South and this area accounts for over half of the total cases of 
AIDS among AAs in the U.S. (2,3).
Risky sexual behaviors, including inconsistent condom use and multiple sexual partners, 
may explain some of the elevated risk of HIV/AIDS among AAs in the Southern U.S. Risky 
sexual behaviors have been linked to cocaine use (4–8), which is among the more frequently 
used illicit drugs in rural and urban areas nationally (9). Cocaine use and risky sexual 
behaviors have become more common among AAs who use cocaine and reside in rural 
communities (4,8,10). Prior multi-state studies of rural people who used stimulants found 
that AAs, most of whom were using cocaine, had greater odds of trading sex for drugs or 
money (8) and multiple sexual partners relative to whites using methamphetamine and/or 
cocaine (4).
Improving access to HIV testing among AAs who use cocaine is an essential first step in 
identifying those who have HIV and could benefit from treatment and counseling. An 
important dimension of access to care is acceptability, which refers to consumers’ attitudes 
about the characteristics of providers and health services organizations (11). In the case of 
HIV testing locales, perceived acceptability of a given HIV testing location may influence 
their likelihood of seeking HIV testing at that site.
A handful of studies have investigated the acceptability or preferences for the location of 
HIV testing (12–15), but none have investigated rural and urban differences. One study of 
rural AAs using cocaine found that many were reluctant to seek HIV testing at local health 
departments or physician clinics due to privacy and stigma concerns (16). An urban-based 
study found that AA men were more likely to be willing to be tested in medical locations, 
such as a hospital or physician’s office, than non-medical settings, such as a church or 
grocery store (12). Another urban study of men who have sex with men (MSM) found that 
respondents were most willing to use rapid home self-testing using saliva and to be tested at 
a physician’s office and were least willing to be tested by means of couples testing and home 
specimen collection with dried blood spotting (13). A study of clients of public testing 
services in San Francisco found that 63% chose public clinics as their first choice for the 
location for HIV testing, while 24% chose home self-testing and only 12% chose a 
physician’s office (14). Lastly, a study conducted in south side Chicago found that 
participants were more likely to favor primary care clinics and multispecialty sites as their 
HIV testing locations over community centers and facilities that only conduct HIV tests 
(15).
The majority of the research described above was conducted in urban settings, but rural and 
urban populations have been shown to differ across many attitudes, beliefs, and behaviors 
(17–24). Rural residents are more likely to stigmatize the use of mental health care (17,19) 
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and exhibit risky health behaviors (20,21) and less likely to receive needed health care 
(18,22). Additionally, rural HIV-infected individuals have been shown to view HIV as more 
stigmatized in their communities and have lower social support when compared to urban 
residents (23). Variations in stigma and other social factors across rural and urban 
communities may also influence the perceptions of the acceptability of HIV testing locations 
in AAs who use drugs.
This study investigated rural vs. urban differences in the acceptability of various HIV testing 
locations as well as other drug use, demographic, social, economic, and health status 
correlates of the acceptability of HIV testing sites. We examined these issues among a 
community-based cohort of rural and urban AAs residing in Arkansas (25). The study 
described in this paper provides new information that could be applied to better target AAs 
who use cocaine and encourage greater overall HIV testing rates.
METHODS
Overview
The data are from a cross-sectional, population-based cohort study of AAs using cocaine 
who were not receiving any substance use treatment. The study was conducted in rural and 
urban counties in the state of Arkansas (26,27). We defined urban/rural residence according 
to the U.S. Office of Management and Budget (OMB) definitions for metropolitan (urban) 
and non-metropolitan (rural) counties (28). The urban county is home to the state capital and 
has a population of 382,748; the 2 rural counties are located along or nearby the Mississippi 
River and have populations of 28,258 and 10,424 (29). The study counties were selected 
because they have sizeable AA populations and prior data from treatment admissions 
showed that cocaine use was the primary drug of abuse among AAs in the state (30).
Eligibility Criteria
The minimum criteria for study eligibility were: (a) age 18 years or older; (b) AA race; (c) 
cocaine use at least 2 times in the past 30 days by any route except for injection; (d) no drug 
treatment services of any kind in the past 30 days, including services at a drug treatment 
facility, counseling for drug use, and self-help meeting attendance; and (e) residence in a 
study county, confirmed by driver’s license or other identification. People who had recently 
used cocaine via injection were excluded because our prior research indicated that injection 
drug use was extremely rare among the population of interest and these types of people who 
use cocaine may be very different than non-injection people who use cocaine (we also note 
that there was no self-reported injection use encountered during screening) (10). To reduce 
the inclusion of participants faking cocaine use in order to receive monetary compensation, 
study recruiters asked each participant four questions about cocaine use and disqualified 
participants who did not answer the questions adequately.
Recruitment and Sampling
Respondent-driven sampling (RDS) was used to identify and recruit participants (31–34). 
RDS is useful in identifying “hidden populations” such as people who use drugs and has 
been shown to produce more representative samples of hidden populations than targeted or 
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snowball sampling (32,33). To initiate study recruitment, trained research staff members 
canvassed areas thought to be frequented by people who use drugs and engaged in 
conversations with community members. Staff members also attended community events, 
visited shelters, and handed out business cards and posted flyers at local health departments, 
courts, and treatment centers. Potential participants were given a study business card and 
instructed to call a study phone number to be screened. Persons who were deemed eligible 
for the study were scheduled for structured in-person interviews at a local study office. All 
participants received $50 cash for completion of the interview and were given three referral 
coupons that they could pass along to others “like them.” Each participant also received $10 
for each referral that resulted in a completed interview. Recruitment occurred between May 
2011 and April 2012, culminating in sample of 400 (200 urban; 200 rural) participants. The 
study was approved by investigators’ university institutional review board and participants’ 
identities were further protected by a Certificate of Confidentiality issued by the National 
Institute on Drug Abuse.
Measures
Dependent Variables—We included items asking each participant to rate the 
acceptability of 8 different HIV testing sites (private physician clinic, local health 
department, community health center, community HIV fair, hospital emergency department, 
blood plasma donation center, drug abuse treatment facility, and mobile van or community 
outreach worker) on the following scale: (1) definitely acceptable, (2) mostly acceptable, (3) 
neutral, (4) mostly unacceptable, and (5) definitely unacceptable. Based on the distributions 
of the responses and cell size concerns, we combined the definitely and mostly acceptable 
responses into a single category and similarly combined the definitely and mostly acceptable 
responses (i.e., a trichotomous definitely/mostly acceptable, neutral, or definitely/mostly 
unacceptable variable) for the partial proportional logistic regression analyses. Because of 
especially small numbers of persons rating the acceptability of private physician clinics and 
local health departments as mostly or definitely unacceptable, we combined these responses 
with the neutral category, thereby creating a binary acceptable vs. other rating for 
multivariable analyses of these variables.
Independent Variables—As mentioned above, we defined urban/rural residence 
according to the OMB definitions of metropolitan and non-metropolitan. Demographic 
variables included age, gender, and education (less than high school vs. high school or 
more). Because access to medical care could be associated with the acceptability of HIV 
testing locations, we also included variables indicating whether the participant visited a 
physician in the past year and had a regular physician, health insurance, and any prior 
history of HIV testing at any location. Because engagement in risky sexual behaviors might 
be associated with the acceptability of HIV testing sites, we included a variable indicating 
whether the participant engaged in any unprotected oral, vaginal, or anal sex within the past 
30 days. We also included a variable for number of other types of drugs used in the last 30 
days and ever being incarcerated. Lastly, we included the Substance Abuse Outcomes 
Module (SAOM), which has been shown to be strongly concordant with the Composite 
International Diagnostic Interview (CIDI-SAM), to assess the presence of past 12-month 
alcohol and cocaine use disorders (35).
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Analysis
Sample characteristics by rural/urban status were compared using t-tests for continuous 
variables and chi-square tests for categorical variables. We then compared and contrasted the 
acceptability of HIV testing sites by rural/urban residence using chi-square tests. Results of 
these analyses are included in Table I and Table II, respectively.
Next, we conducted logistic regression analyses to estimate unadjusted and adjusted odds 
ratios (ORs) and 95% confidence intervals (95%CIs) to compare rural/urban differences in 
the acceptability of 3 HIV testing locations: (1) local health departments and (2) physician 
offices, as these were the locations with the greatest acceptability among participants, and 
(3) drug abuse treatment centers, as this location is of particular interest given the target 
population of the study. Specifically, we first conducted proportional odds logistic regression 
analyses with each of the 3 main dependent variables of interest treated as having a 3 level 
ordinal value (i.e., acceptable, neutral, and unacceptable). However, because several 
variables within each model did not meet the proportional odds assumption, we moved to 
estimate a partial proportional odds model. This type of model treats independent variables 
that do not satisfy the proportional odds assumption as non-proportional while treating those 
that satisfy the assumption as proportional. The proportional odds assumption is that the 
odds ratios at any given break point in the ordinal dependent variable are not statistically 
different and therefore a single summary odds ratio can be provided for variables meeting 
the proportional odds assumption (36,37). In contrast, when a variable does not meet the 
proportional odds assumption, odds ratios must be provided at each break point for the 
dependent variable.
The proportional odds models for 2 of the dependent variables (the acceptability of local 
health departments and physician offices) yielded odds ratios with very wide confidence 
intervals corresponding to several independent variables, which were attributable to small 
sizes (0–5) for some levels of the dependent variable. Based on the distributions of the 
responses and cell size concerns, we ultimately decided to report the binary logistic 
regression results modeling the odds of acceptability (definitely/mostly acceptable vs. 
neutral/mostly/definitely unacceptable) of local health departments and physician offices 
(Table III) and the partial proportional odds regression results modeling the acceptability 
(definitely/mostly acceptable, neutral, and mostly/definitely unacceptable) of the drug 
treatment centers (Table IV).
Four respondents, all from the urban county, reported positive HIV status and were excluded 
from all multivariable analyses. Missing values were excluded from the multivariable 
analyses, culminating in final sample sizes ranging from 392 to 396 depending on the 
dependent variable analyzed. Finally, we calculated RDS weights for each dependent 
variable using the RDS Analysis Tool 7.1.46 developed by Heckathorn (available at http://
www.respondentdrivensampling.org/) and applied these weights in the multivariable 
analyses. Because of their potential confounding effects, we included all independent 
variables in the multivariable analyses.
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RESULTS
Table I describes rural/urban differences in study participant characteristics. Rural residents 
were significantly less likely to have a high school diploma than urban residents (62.5%% 
vs. 73.0%, p=0.03), more likely to have had a doctor visit within the last year (25.5% vs. 
12.2%, p<0.001), and more likely to have a regular doctor (40% vs. 21.4%, p<0.001). They 
were also more likely to have engaged in unprotected sex within the last 30 days (34.5 vs. 
22%, p=0.006), more likely to have ever been incarcerated (59.0% vs. 48.5%), and more 
likely to have used other types of drugs in addition to cocaine in the last 30 days (p-
value=0.001), with 57.0% using 1 additional drug and 21.5% using 2 or more additional 
types of drugs compared to 50.5% and 12.2% for urban residents, respectively.
The sample did not vary significantly by residence across the other characteristics (age, 
gender, having health insurance, having previously been tested for HIV, a cocaine use 
disorder in last 12 months, and an alcohol use disorder in last 12 months). Mean age of rural 
residents was 39.1 (SD=12.1) and was 39.1 (SD=10.8) for urban. Approximately one third 
of the sample was female for both groups (rural=38.5%; urban=34.7%). A minority of 
participants had health insurance, with 31.0% of rural and 26.0% of urban residents having 
some form of coverage. Most participants had been previously tested for HIV (rural=87.0%; 
urban=80.6%). Finally, more than 3/4 of residents met the criteria for a cocaine use disorder 
(rural=77.5%; urban=76.5%) and more than half met the criteria for an alcohol use disorder 
(rural=64.0%; urban=55.1%).
Table II describes rural-urban differences in the acceptability of each of the HIV testing 
locations. Rural residents were significantly less likely than urban residents to find 6 of the 8 
sites to be acceptable locations for HIV testing: a) local health departments (79% vs. 97%, 
p<0.001), b) private physician clinic (80% vs. 95%, p<0.001), c) physician clinics (77% vs. 
95%, p<0.001), d) hospital emergency departments (71% vs. 93%, p<0.001), e) community 
HIV fairs (72% vs. 84%, p<0.012), and f) drug abuse treatment facilities (63% vs. 77%, 
p=0.007). There were no statistically significant rural vs. urban differences in acceptability 
across the other two locations: g) blood plasma donation center (66% vs. 61%, p=0.411) and 
h) mobile van/community outreach worker (52% vs. 53%, p=0.139).
Table III shows the results from binary logistic regression analysis comparing rural-urban 
differences in the odds of identifying a location as an acceptable HIV testing site. As 
described in the methods section, we focused the binary logistic regression analyses on the 
two locations that were found to be most acceptable among the sample: local health 
departments and physician offices.
In the adjusted model for local health departments, rural residence (OR=0.09; 95%CI: 0.03, 
0.21) and having an alcohol use disorder (OR=0.33; 95%CI: 0.14, 0.74) were associated 
with decreased odds of finding the location as an acceptable HIV testing site, while having 
previously had an HIV test had a significant positive association (OR=3.85; 95%CI: 1.67, 
8.87). The adjusted model showed no significant associations between the outcome and age 
(OR=1.01; 95%CI:0.98, 1.04), female gender (OR=1.47; 95%CI: 0.66, 3.28), having a high 
school diploma or greater education (OR=0.71; 95%CI: 0.35, 1.43), having health insurance 
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(OR=0.57; 95%CI: 0.27, 1.20), having a doctor’s visit in the last year (OR=0.92; 95%CI: 
0.42, 2.02), having a regular doctor (OR=1.31; 95%CI: 0.60, 2.84), engaging in unprotected 
sex in the past 30 days (OR=0.82; 95%CI: 0.42, 1.63), ever being incarcerated (OR=0.76; 
95%CI: 0.36, 1.62), a cocaine use disorder (OR=1.10; 95%CI: 0.46, 2.60), and using one 
additional (OR=1.40; 95%CI: 0.61, 3.20) or two or more additional (OR=0.84; 95%CI: 0.30, 
2.30) drugs other than cocaine in the past 30 days. However, engaging in unprotected sex in 
the past 30 days (OR=0.56; 95%CI: 0.32, 0.99), ever being incarcerated (OR=0.56; 95%CI: 
0.31, 0.99), and using two or more additional drugs other than cocaine in the past 30 days 
(OR=0.36; 95%CI: 0.16, 0.80) were significant in the unadjusted analysis.
In the adjusted model for physician offices, rural residence (OR=0.19; 95%CI: 0.09, 0.42), 
having had unprotected sex (OR=0.40; 95%CI: 0.20, 0.78), and having an alcohol use 
disorder (OR=0.31; 95%CI: 0.14, 0.70) were associated with a decreased odds of finding the 
location as an acceptable HIV testing site, while having a high school diploma or greater 
education (OR=1.97; 95%CI: 1.01, 3.85) and having previously been tested for HIV 
(OR=2.51; 95%CI: 1.11, 5.68) had significant positive associations. The adjusted model 
showed no significant associations between the acceptability of physician offices and age 
(OR=0.99; 95%CI: 0.96, 1.02), female gender (OR=2.04; 95%CI: 0.90, 4.61), having health 
insurance (OR=1.24; 95%CI: 0.56, 2.76), having a doctor’s visit in the last year (OR=2.10; 
95%CI: 0.83, 5.29), having a regular doctor (OR=0.68; 95%CI: 0.31, 1.51), ever being 
incarcerated (OR=1.90; 95%CI: 0.91, 3.98), a cocaine use disorder (OR=0.61; 95%CI: 0.23, 
1.57), and using one additional (OR=0.80; 95%CI: 0.34, 1.86) or two or more additional 
(OR=0.73; 95%CI: 0.25, 2.13) drugs other than cocaine in the past 30 days.
Table IV describes the results of the partial proportional odds model for the acceptability of 
drug treatment centers as HIV testing sites. Of the independent variables that satisfied with 
proportional odds assumption, as distinguished in Table IV, rural residence (OR=0.49; 
95%CI: 0.30, 0.80) was associated with a decreased adjusted odds of finding the location as 
more acceptable, while age (OR=1.05; 95%CI: 1.02, 1.07) was associated with an increased 
odds of finding it as more acceptable. The adjusted model showed no significant 
associations between the acceptability of drug use treatment centers as an HIV testing site 
and having a high school diploma or greater education (OR=0.99; 95%CI: 0.60, 1.61), 
health insurance (OR=0.86; 95%CI: 0.49, 1.51), a doctor’s visit in the last year (OR=1.00; 
95%CI: 0.55, 1.81), a regular doctor (OR=0.80; 95%CI: 0.45, 1.40), unprotected sex in the 
past 30 days (OR=0.93; 95%CI: 0.56, 1.53), prior incarceration (OR=0.86; 95%CI: 0.50, 
1.47), prior HIV testing (OR=0.92; 95%CI: 0.48, 1.77), an alcohol use disorder (OR=0.60; 
95%CI: 0.35, 1.01), and using one additional (OR=1.26; 95%CI: 0.71, 2.23) or two or more 
additional (OR=1.40; 95%CI: 0.65, 3.00) drugs other than cocaine in the past 30 days.
Two independent variables, gender and cocaine use disorder status, did not satisfy the 
proportional odds assumptions. Female gender was positively associated with greater odds 
of finding a drug use treatment center as acceptable than neutral/unacceptable (OR=1.78; 
95%CI: 1.01, 3.15), but was not significantly associated with finding a drug use treatment 
center as acceptable/neutral than unacceptable (OR=1.07; 95%CI: 0.51, 2.24). Having a 
cocaine use disorder showed no significant association in either comparison.
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DISCUSSION
AAs, particularly those residing in the Southern region of the U.S., have an elevated risk of 
HIV/AIDS. Within the South, the AIDS case rate is comparatively high among urban as well 
as rural AAs relative to their white counterparts (38). In the Southern state of Arkansas, 
where we conducted the study described in this paper, the HIV incidence rate among AAs is 
approximately 5 times higher than the incidence rate among whites (39). Given the elevated 
risk of HIV among AAs, particularly among those who reside in the South and use cocaine, 
it is important to understand how they view the acceptability of potential HIV testing sites.
A small body of research on HIV testing preferences and acceptability has largely focused 
on urban residents. Similar to an urban-based study of public testing service clients (14), we 
found that the vast majority of both urban and rural AAs who use drugs viewed public health 
departments and community health centers as acceptable HIV testing sites. Also similar to 
urban-based studies of urban AA men (12) and MSM (13), we found that the vast majority 
of both urban and rural AAs who use cocaine view a physicians’ office as an acceptable HIV 
testing location. Medical care clinics have the potential to serve as a key venue for HIV 
testing, especially in the rural populations that we studied as they were significantly more 
likely to have had a doctor visit in the last year (25.2% vs. 12.2%, p<0.001) and to have a 
regular doctor (40% vs. 21.4%, p<0.001) than their urban counterparts. However, physician 
visit rates would likely need to be improved to facilitate clinic-based HIV testing. Increased 
health insurance coverage through the expansion of Medicaid and development of health 
exchanges has occurred as part of the Affordable Care Act since this study was conducted 
and could help to facilitate access to physician services and HIV testing, but other non-
financial barriers to medical care may persist among rural and urban AAs. Lastly, “opt-out” 
HIV testing policies have been shown to improve acceptance of HIV screening over “opt-in” 
policies in emergency departments (40,41). Given that local health departments and 
physician offices had the highest acceptability in both rural and urban respondents, 
adaptation of “opt-out” HIV testing may be beneficial in these settings to improve HIV 
screening rates among high risk populations.
Although the majority of rural participants viewed local health departments, community 
health centers, or private physician clinics as acceptable HIV testing sites, they were 
substantially less likely to view these sites as acceptable relative to their urban counterparts. 
Exactly why fewer rural people who use cocaine find HIV testing sites as acceptable 
remains unclear, but we posit that it could be explained by doubts about the need for HIV 
testing, stigma associated with getting tested, and concern about the confidentiality of testing 
results, which were cited as barriers to HIV testing in a qualitative research study conducted 
among rural AAs using cocaine in Arkansas (42). In related research, we found that worse 
perceptions of the effectiveness of local substance use treatment was negatively associated 
with a preference to seek local over non-local substance use treatment (43). Similarly, 
perceptions of the accessibility and availability of HIV testing locations may contribute to 
perceptions of their acceptability. Every county in the state of Arkansas houses a health 
department and one study reported that 87% of county public health clinics in rural counties 
of 10 southern states offer HIV testing (44), which suggests at least some minimal potential 
access to HIV testing. Although the two adjacent rural counties where we conducted this 
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research have medical care providers and outpatient substance use treatment available, these 
services are arguably not as easily accessible as they are in larger population areas.
The integration of HIV testing within drug use treatment centers could potentially facilitate 
HIV testing, at least among persons making the decision to seek formal treatment. A 
community-based study of mostly AAs who use drugs in Kentucky found that prior 
treatment for drug use was associated with a greater likelihood of prior HIV testing (45). 
Another study found that a history of substance abuse treatment was positively associated 
with the number of self-reported HIV tests in unadjusted analysis, but this association did 
not remain significant when adjusting for other factors (46). Other research has shown that 
HIV education included as part of a formal methadone treatment program is effective in 
improving awareness of HIV risk and reducing risky sexual behaviors (47). In recognition of 
the potential benefits of integrating HIV testing and substance use treatment, both the 
Centers for Disease Control and Prevention (48) and Veterans Administration (VA) 
recommend that all persons being treated at substance abuse facilities be tested for HIV (49). 
However, prior research indicates that the majority of substance abuse facilities do not offer 
HIV testing (42,50). Despite these potential advantages, this study suggests that integration 
of testing in drug treatment centers may encounter some barriers, particularly in rural 
settings.
Our findings also indicate that rural AAs using cocaine less frequently view drug use 
treatment centers as an acceptable HIV testing site relative to their urban counterparts. One 
plausible explanations is that some study participants contemplated the difficulty or learning 
about a potential HIV diagnosis within the confines of substance use treatment while 
attempting to reduce their drug use. Also, because rural AAs using cocaine are also less 
likely to perceive a need for drug use treatment (26,27), which is strongly correlated with 
actual treatment utilization, and face greater geographic barriers to drug use treatment (51–
53), the integration of HIV testing with drug use treatment may be less effective in reaching 
rural AA people who use cocaine.
Of note, age and female gender were positively associated with the acceptability of drug use 
treatment facilities as HIV testing sites. Older people who use cocaine may have had more 
interactions with drug use treatment and, as a result, may be more comfortable with the 
thought of being tested for HIV in this setting. We are not sure why women find drug use 
treatment sites as more acceptable than men. However, this finding points to a potential 
strategy of targeting HIV testing toward female AA people who use cocaine who have 
entered the treatment system.
Finally, persons meeting criteria for an alcohol use disorder were significantly less likely to 
find local health departments and physician offices to be acceptable HIV testing sites. One 
explanation for the latter finding is people who use cocaine with an additional alcohol use 
problem are less concerned about their overall need for HIV testing. In other words, lower 
perceived need for HIV testing may translate into lower acceptability of a wide range of HIV 
testing sites.
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Limitations
The cross-sectional design of the study prevents us from making conclusions about temporal 
relationships between explanatory factors and perceptions of acceptable HIV testing 
locations. Also, the study sample was taken through respondent-driven sampling, but it is 
difficult to obtain a truly random sample when studying “hidden” populations such as people 
who use drugs. Additionally, it should be noted that asking about acceptability of HIV 
testing location does not necessarily equate to utilization. In order to improve testing rates 
identification of acceptable locations is just the first step and improving access, availability, 
and utilization of these locations will be key toward this goal. Another potential weakness 
was the inclusion of a ‘neutral’ response option in the Likert scale for the acceptability 
variables, which creates issues with analysis and interpretation. However, we conducted 
additional analyses in an attempt to mitigate these concerns and regardless of the method 
used the major findings of the study were consistent. It is also important to note that the 
lower acceptability of drug use treatment centers compared to private physician clinics and 
local health departments may be attributed to the fact that participants in the survey were not 
engaged in treatment. AAs using cocaine who are engaged in substance use treatment may 
have different acceptability ratings than the population in this study. Finally, the findings of 
the study may only be generalizable to AAs residing in Arkansas, although it is reasonable 
to assume that the results could be generalizable to other southern states in the U.S. that have 
similar populations to Arkansas.
CONCLUSIONS
Overall, rural AAs who use cocaine were found to view common HIV testing sites as less 
acceptable than their urban counterparts. Local health departments, physician clinics, and 
community health centers were found to be the most acceptable sites among both rural and 
urban residents and may be the best sites for programs designed to improve HIV testing 
rates. Policy-makers have recently encouraged the provision of HIV testing within drug use 
treatment centers. However, our findings suggest that some AAs who use cocaine, 
particularly those living in the rural South, find drug use treatment as an unacceptable setting 
for HIV testing. Understanding the reasons behind these perceptions and ways to change 
them will be important to improve integration of HIV testing in various health care settings. 
Finally, future studies of rural residents that include stratification of sub-groups within this 
population may be beneficial in order to elucidate demographic and other characteristics 
associated with finding certain locations as acceptable HIV testing sites.
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